Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chemotherapy-Related Cognitive Impairment × Ashwagandha × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteosarcoma 1 Neoplasms 1 Inflammation 1 Cognitive Dysfunction 1 Chemotherapy-Related Cognitive Impairment 1 Autoimmune Diseases 1

Interventions

Cognitive Training 2 Vitamin D 1 Tobacco Use Cessation Devices 1 Synbiotics 1 Sodium Chloride 1 Saline Solution 1 Prebiotics 1 Palliative Care 1 Neuroprotective Agents 1 Mesna 1 Magnetic Resonance Spectroscopy 1 High-Intensity Interval Training 1 Functional Status 1 Electroacupuncture 1 Doxorubicin 1 Cyclophosphamide 1 Ashwagandha 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Sutter Health

Phase 2 Unknown

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡